Variant report

Variant	nsv601174
Chromosome Location	chr6:26341301-26350938
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:43)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:43 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:26350096..26351709-chr6:26521212..26523157,2	K562	blood:
2	chr6:26339701..26341398-chr6:26520841..26522748,2	MCF-7	breast:
3	chr6:26343594..26345212-chr6:26474079..26475915,2	K562	blood:
4	chr6:26341837..26342412-chr6:26411698..26412292,2	MCF-7	breast:
5	chr6:26340614..26342213-chr6:26550720..26552761,2	K562	blood:
6	chr6:26345126..26347534-chr6:26601972..26604774,2	K562	blood:
7	chr6:26341191..26342496-chr6:26493295..26494195,4	MCF-7	breast:
8	chr6:26338579..26343405-chr6:26519686..26522615,5	K562	blood:
9	chr6:26340224..26342444-chr6:26572464..26573981,2	K562	blood:
10	chr6:26345077..26347178-chr6:26389815..26392658,2	K562	blood:
11	chr6:26341150..26343678-chr6:26575652..26577197,2	K562	blood:
12	chr6:26342033..26344696-chr6:26521826..26523631,2	MCF-7	breast:
13	chr6:26340367..26342068-chr6:26565730..26567496,2	K562	blood:
14	chr6:26340224..26344158-chr6:26569567..26573981,6	K562	blood:
15	chr6:26350529..26353058-chr6:26354416..26356563,2	K562	blood:
16	chr6:26336805..26339023-chr6:26339169..26341807,3	MCF-7	breast:
17	chr6:26340033..26342028-chr6:26415409..26417011,2	MCF-7	breast:
18	chr6:26341932..26342432-chr6:26543775..26544497,2	MCF-7	breast:
19	chr6:26340823..26342973-chr6:26490879..26493737,2	K562	blood:
20	chr6:26342125..26345094-chr6:26474079..26475850,2	K562	blood:
21	chr6:26340332..26342039-chr6:26569832..26571583,2	K562	blood:
22	chr6:26339658..26342406-chr6:26483476..26486207,2	K562	blood:
23	chr6:26341882..26342492-chr6:26420774..26421520,2	MCF-7	breast:
24	chr6:26341984..26342515-chr6:26596029..26596572,2	MCF-7	breast:
25	chr6:26272455..26274796-chr6:26340559..26343243,3	MCF-7	breast:
26	chr6:26342168..26345048-chr6:26509847..26512007,2	MCF-7	breast:
27	chr6:26341496..26342438-chr6:26493055..26494222,5	K562	blood:
28	chr1:17222072..17224236-chr6:26350716..26352236,2	K562	blood:
29	chr6:26341541..26342734-chr6:26595701..26596713,9	K562	blood:
30	chr6:26346737..26349010-chr6:26483438..26485200,2	K562	blood:
31	chr6:26338939..26342494-chr6:26519686..26522747,3	K562	blood:
32	chr6:26323184..26324056-chr6:26341539..26342363,2	K562	blood:
33	chr1:17221559..17223078-chr6:26350716..26352216,2	MCF-7	breast:
34	chr6:26341644..26342483-chr6:26450003..26451206,4	MCF-7	breast:
35	chr6:26339310..26342101-chr6:26554337..26555953,2	K562	blood:
36	chr6:26341264..26342451-chr6:26569043..26570054,3	K562	blood:
37	chr6:26339036..26342767-chr6:26596200..26598139,3	K562	blood:
38	chr6:26341478..26343917-chr6:26362438..26365038,2	K562	blood:
39	chr6:26340127..26342724-chr6:26570668..26572890,2	MCF-7	breast:
40	chr6:26341603..26342500-chr6:26520725..26521500,3	K562	blood:
41	chr6:26345080..26346941-chr6:26520838..26522730,2	K562	blood:
42	chr6:26331178..26331773-chr6:26341935..26342536,2	K562	blood:
43	chr6:26346422..26348741-chr6:26456867..26458564,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000199289	chromatin interactions
ENSG00000168242	chromatin interactions
ENSG00000207005	chromatin interactions
ENSG00000218690	chromatin interactions
ENSG00000112763	chromatin interactions
ENSG00000146109	chromatin interactions
ENSG00000124508	chromatin interactions
ENSG00000228223	chromatin interactions

Extended variants
information (count: 351 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:351 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9467715	chr6:26341301-26341302	Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	mRNA abundance
2	rs576233263	chr6:26341312-26341313	Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs11753487	chr6:26341314-26341315	Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs559941355	chr6:26341331-26341332	Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs574022039	chr6:26341401-26341402	Weak transcription Enhancers Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs542935894	chr6:26341436-26341437	Weak transcription Enhancers Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs181553133	chr6:26341474-26341475	Weak transcription Enhancers Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs372733497	chr6:26341493-26341494	Weak transcription Enhancers Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs75652102	chr6:26341560-26341561	Weak transcription Enhancers Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs77715426	chr6:26341596-26341597	Weak transcription Enhancers Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs540032751	chr6:26341631-26341632	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs147357938	chr6:26341652-26341653	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs530901039	chr6:26341669-26341670	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs139417395	chr6:26341678-26341679	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs368430277	chr6:26341699-26341700	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs142501099	chr6:26341701-26341702	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs372025356	chr6:26341723-26341724	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs114332974	chr6:26341745-26341746	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs540622549	chr6:26341747-26341748	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs557558444	chr6:26341780-26341781	Flanking Active TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs114864671	chr6:26341814-26341815	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs560820773	chr6:26341846-26341847	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs77720482	chr6:26341877-26341878	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs557457973	chr6:26341882-26341883	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs74293951	chr6:26341883-26341884	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs74356777	chr6:26341885-26341886	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs184445184	chr6:26341978-26341979	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs573912599	chr6:26341993-26341994	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs542772522	chr6:26342001-26342002	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs371514956	chr6:26342019-26342020	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs549553348	chr6:26342121-26342122	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs553255999	chr6:26342137-26342138	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs573457253	chr6:26342155-26342156	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs79877916	chr6:26342163-26342164	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs530939332	chr6:26342186-26342187	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs545427530	chr6:26342189-26342190	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs565121137	chr6:26342228-26342229	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs369079531	chr6:26342235-26342236	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs189508696	chr6:26342237-26342238	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs373896618	chr6:26342245-26342246	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs35851113	chr6:26342266-26342267	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs372441686	chr6:26342307-26342308	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs34268143	chr6:26342312-26342313	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs367749396	chr6:26342317-26342318	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs570802547	chr6:26342455-26342456	Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs74741815	chr6:26342456-26342457	Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs546983239	chr6:26342500-26342501	Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs374772018	chr6:26342572-26342573	Active TSS Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs559723155	chr6:26342637-26342638	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs566004651	chr6:26342666-26342667	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Williams-beuren syndrome	16971481	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Autism	22495309	CNVD
Lung cancer	21569311	CNVD
Breast cancer	21509527	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Autism	20531469	CNVD
Pancreatic cancer	17952125	CNVD
Acute lymphoblastic leukemia	19100363	CNVD

Chromatin state (count:320 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26333000-26341600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr6:26333000-26342200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr6:26336200-26341800	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr6:26337000-26341400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr6:26337000-26341600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
6	chr6:26337000-26342000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
7	chr6:26337200-26342000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr6:26337200-26342000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
9	chr6:26337200-26342000	Weak transcription	Primary T helper cells fromperipheralblood	blood
10	chr6:26337400-26341600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
11	chr6:26337400-26341600	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr6:26337400-26341600	Weak transcription	Dnd41	blood
13	chr6:26337400-26341800	Weak transcription	Primary T helper cells PMA-I stimulated	--
14	chr6:26337400-26341800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
15	chr6:26337400-26341800	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr6:26337400-26342000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr6:26337400-26342000	Weak transcription	Monocytes-CD14+_RO01746	blood
18	chr6:26337400-26342200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
19	chr6:26337400-26342200	Weak transcription	NHDF-Ad	bronchial
20	chr6:26337600-26341400	Weak transcription	HUES6 Cell Line	embryonic stem cell
21	chr6:26337600-26341400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr6:26337600-26341400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
23	chr6:26337600-26341400	Weak transcription	Hela-S3	cervix
24	chr6:26337600-26341800	Weak transcription	Primary monocytes fromperipheralblood	blood
25	chr6:26337600-26341800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr6:26337600-26342200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr6:26337600-26342200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr6:26337600-26342200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
29	chr6:26337600-26342200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr6:26337600-26342200	Weak transcription	HUVEC	blood vessel
31	chr6:26337600-26342200	Enhancers	K562	blood
32	chr6:26337600-26342200	Weak transcription	NHEK	skin
33	chr6:26337600-26342200	Weak transcription	NHLF	lung
34	chr6:26337800-26342200	Weak transcription	HMEC	breast
35	chr6:26339600-26341600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr6:26340200-26342000	Weak transcription	NH-A	brain
37	chr6:26340600-26341600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
38	chr6:26340800-26341800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr6:26341000-26341800	Weak transcription	Osteobl	bone
40	chr6:26341200-26341600	Enhancers	HepG2	liver
41	chr6:26341200-26341800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr6:26341200-26341800	Enhancers	GM12878-XiMat	blood
43	chr6:26341400-26341600	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr6:26341400-26341600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr6:26341400-26342000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr6:26341400-26342000	Enhancers	Hela-S3	cervix
47	chr6:26341400-26342200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr6:26341400-26343000	Active TSS	HUES64 Cell Line	embryonic stem cell
49	chr6:26341600-26341800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
50	chr6:26341600-26341800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links